During the period 1998-2015, the global marine pharmaceutical preclinical pipeline involved research with more than 1,000 marine chemicals which demonstrated antibacterial, anticoagulant, anti-inflammatory, antifungal, anthelmintic, antiplatelet, antiprotozoal, and antiviral activities; actions on the cardiovascular, endocrine, immune, and nervous systems; and other miscellaneous mechanisms of action. The marine pharmaceutical preclinical pipeline is reviewed in the following 17 peer-reviewed articles:
| 17. |
Mayer, A.M.S., A.J. Guerrero, A.D. Rodriguez, Orazio Taglialatela-Scafati, F. Nakamura, and N. Fusetani. Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-inflammatory, Antiprotozoal, Antituberculosis, Antiviral and Anthelmintic Activities; affecting the Immune and Nervous System, and other Miscellaneous Mechanisms of Action. MARINE DRUGS 18, 5, 2019. Published on December 19, 2019 and available at https://www.mdpi.com/1660-3397/18/1/5 |
| 16. | Mayer, A.M.S., A.D. Rodriguez, Orazio Taglialatela-Scafati and N. Fusetani. Marine pharmacology in 2012-2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; affecting the Immune and Nervous System, and other Miscellaneous Mechanisms of Action. MARINE DRUGS 15:273-334, 2017. Published on August 29, 2017 and available at http://www.mdpi.com/1660-3397/15/9/273 |
| 15. | Mayer, A.M.S., A.D. Rodriguez, Orazio Taglialatela-Scafati and N. Fusetani. Marine pharmacology in 2009-11: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; affecting the Immune and Nervous System, and other Miscellaneous Mechanisms of Action. MARINE DRUGS 11:2510-2573, 2013. Published July 16, 2013 and available at http://www.mdpi.com/1660-3397/11/7/2510 |
| 14. | Mayer, A.M.S., A.D. Rodriguez, R. Berlinck and N. Fusetani. Marine pharmacology in 2007-8: Marine Compounds with Antibacterial, Anticoagulant, Antifungal, Anti-inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; affecting the Immune and Nervous System, and other Miscellaneous Mechanisms of Action. Comparative Biochemistry and Physiology Part C: 153: 191-222, 2011. PubMed Abstract PDF Doc |
| 13. | K.B. Glaser and Mayer, A.M.S. A Renaissance in Marine Pharmacology: From Preclinical Curiosity to Clinical Reality. Biochemical Pharmacology 78: 440-448, 2009. PubMed Abstract PDF Doc |
| 12. | Mayer, A.M.S., A.D. Rodriguez, R. Berlinck and M.T. Hamann. Marine pharmacology in 2005-6: Marine Compounds with Antibacterial, Anticoagulant, Antifungal, Anthelmitic, Anti-inflammatory, Antiprotozoal, and Antiviral Activities; affecting the Cardiovascular, Endocrine, Immune and Nervous Systems and other Miscellaneous Mechanisms of Action. Biochimica et Biophysica Acta, General Subjects, 1790: 283-308, 2009 PubMed Abstract PDF Doc |
| 11. | Mayer, A.M.S. and K. R. Gustafson. Marine Pharmacology in 2005-6: Antitumor and Cytotoxic Compounds. European Journal of Cancer 44:2357-2387, 2008. PubMed Abstract PDF Doc |
| 10. | Mayer, A.M.S., A.D. Rodriguez, R. Berlinck and M. T. Hamann. Marine pharmacology in 2003-4: Marine Compounds with Anthelminthic, Antibacterial, Anticoagulant, Antifungal, Anti-inflammatory, Antimalarial, Antiplatelet, Antiprotozoal, Antituberculosis, and Antiviral Activities; affecting the Cardiovascular, Immune and Nervous Systems and other Miscellaneous Mechanisms of Action. Comparative Biochemistry and Physiology Part C:145: 553-581, 2007 PubMed Abstract PDF Doc |
| 9. | Mayer, A.M.S. and K. R. Gustafson, Marine Pharmacology in 2003-4: Antitumor and Cytotoxic Compounds. European Journal of Cancer 43:2241-2270, 2006. PubMed Abstract PDF Doc |
| 8. | Mayer, A.M.S. and M. T. Hamann. Marine pharmacology in 2001-2: Marine Compounds with Antibacterial, Anticoagulant, Antifungal, Anti-inflammatory, Antimalarial, Antiplatelet, Antiprotozoal, Antituberculosis, and Antiviral Activities; affecting the Cardiovascular, Immune and Nervous Systems and other Miscellaneous Mechanisms of Action. Comparative Biochemistry and Physiology Part C 140(3-4):265-286, 2005. PubMed Abstract PDF Doc |
| 7. | Mayer, A.M.S. and K. R. Gustafson, Marine Pharmacology in 2001-2: Antitumor and Cytotoxic Compounds. European Journal of Cancer 40(18) 2676-2704, 2004. PubMed Abstract PDF Doc |
| 6. | Mayer, A.M.S. and M. T. Hamann. Marine pharmacology in 2000: Marine Compounds with Antibacterial, Anticoagulant, Antifungal, Anti-inflammatory, Antimalarial, Antiplatelet, Antiprotozoal, Antituberculosis, and Antiviral Activities; affecting the Cardiovascular, Immune and Nervous Systems and other Miscellaneous Mechanisms of Action, Marine Biotechnology, 6: 37-52, 2004. PubMed Abstract PDF Doc |
| 5. | Mayer, A.M.S. and K. R. Gustafson, Marine Pharmacology in 2000: Antitumor and Cytotoxic Compounds. International Journal of Cancer 105: 291-299, 2003. PubMed Abstract PDF Doc |
| 4. | Mayer, A.M.S. and M. T. Hamann. Marine pharmacology in 1999: Marine Compounds with Antibacterial, Anticoagulant, Antifungal, Anthelmintic, Anti-inflammatory, Antiplatelet, Antiprotozoal, and Antiviral Activities; affecting the Cardiovascular, Endocrine, Immune and Nervous Systems and other Miscellaneous Mechanisms of Action, Comparative Biochemistry and Physiology, Part C 132/3: 315-339, 2002. PubMed Abstract PDF Doc |
| 3. | Mayer, A.M.S. and V.K.B. Lehmann. Marine Pharmacology in 1999: Antitumor and Cytotoxic Compounds. Anticancer Research 21: 2489-2500, 2001. PubMed Abstract PDF Doc |
| 2. | Alejandro M. S. Mayer and Virginia K. B. Lehmann, Marine Pharmacology in 1998: Marine Compounds with Antibacterial, Anticoagulant, Anti-inflammatory, Anthelmintic, Antiplatelet, Antiprotozoal, and Antiviral Activities; with actions on the Cardiovascular, Endocrine, Immune, and Nervous Systems; and other Miscellaneous Mechanisms of Action . ThePharmacologist 42(2):62-69, 2000. PDF Doc |
| 1. | Alejandro M. S. Mayer, Marine Pharmacology in 1998: Antitumor and Cytotoxic Compounds.The Pharmacologist41(4):159-164, 1999. PDF Doc |